product summary
Loading...
company name :
MedChem Express LLC
product type :
antibody
product name :
NF-KB p65 Antibody
catalog :
HY-P80765
quantity :
10 μL;50 μL;100 μL
price :
70;185;300 USD
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
YA268
reactivity :
human
application :
western blot, immunocytochemistry, immunoprecipitation, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
more info or order :
product information
Catalog Number :
HY-P80765
Product Name :
NF-KB p65 Antibody
Product Type :
antibody
Host Species :
Rabbit
Clonality :
Monoclonal Antibody
Conjugation :
Unconjugated
Clone Name :
YA268
Size :
10 μL;50 μL;100 μL
List Price :
70;185;300 USD
Product Description :
Primary Antibodies
CrossReactivity :
Human, Mouse
Background :
NF-KB p65: NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
ALTnames :
NFKB3; RELA; TF65; Transcription factor p65; p65; NFkB
Immunogen :
Synthetic peptide corresponding to Human NF-kB p65.The exact sequence is proprietary to MCE.
Buffer :
Supplied in 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol and 0.05% BSA. Preservative: 0.01% Sodium azide
Application Summary :
WB, IHC-F, IHC-P, ICC/IF, IP
Storage :
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
more info or order :
company information

MedChem Express LLC
18 Wilkinson Way, Princeton, NJ 08540
sales@medchemexpress.com
http://www.medchemexpress.com609-228-6898
headquarters: USA
related products
browse more products
questions and comments